Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAjuvenate Study of LY3337641 in Rheumatoid Arthritis
jRCT2080223586Phase 2
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of poseltinib in rheumatoid arthritis (RA) (8 arms), sponsored by Eli Lilly and Company.
02
Drugs
poseltinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on jRCT2080223586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223586.